[go: up one dir, main page]

AU6251594A - Treatment of cancerous growths with biologically active peptides and protease inhibitors - Google Patents

Treatment of cancerous growths with biologically active peptides and protease inhibitors

Info

Publication number
AU6251594A
AU6251594A AU62515/94A AU6251594A AU6251594A AU 6251594 A AU6251594 A AU 6251594A AU 62515/94 A AU62515/94 A AU 62515/94A AU 6251594 A AU6251594 A AU 6251594A AU 6251594 A AU6251594 A AU 6251594A
Authority
AU
Australia
Prior art keywords
treatment
biologically active
protease inhibitors
active peptides
cancerous growths
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62515/94A
Other languages
English (en)
Inventor
Meenhard Herlyn
Leonard S Jacob
W. Lee Maloy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Magainin Pharmaceuticals Inc
Original Assignee
Magainin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magainin Pharmaceuticals Inc filed Critical Magainin Pharmaceuticals Inc
Publication of AU6251594A publication Critical patent/AU6251594A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1751—Bactericidal/permeability-increasing protein [BPI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU62515/94A 1993-02-26 1994-02-22 Treatment of cancerous growths with biologically active peptides and protease inhibitors Abandoned AU6251594A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2160793A 1993-02-26 1993-02-26
US021607 1993-02-26
PCT/US1994/002121 WO1994019369A1 (fr) 1993-02-26 1994-02-22 Traitement de tumeurs cancereuses au moyen d'inhibiteurs de protease et de peptides a activite biologique

Publications (1)

Publication Number Publication Date
AU6251594A true AU6251594A (en) 1994-09-14

Family

ID=21805153

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62515/94A Abandoned AU6251594A (en) 1993-02-26 1994-02-22 Treatment of cancerous growths with biologically active peptides and protease inhibitors

Country Status (2)

Country Link
AU (1) AU6251594A (fr)
WO (1) WO1994019369A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9504761D0 (en) * 1995-03-09 1995-04-26 Unilever Plc Amphiphilic peptide and analogs thereof
FR2735983B1 (fr) 1995-06-29 1997-12-05 Centre Nat Rech Scient Peptide permettant de modifier l'activite du systeme immunitaire humain ou animal
US6066319A (en) * 1996-04-30 2000-05-23 President And Fellows Of Harvard College Drug delivery using terminal complement components
US8318899B2 (en) 2008-01-24 2012-11-27 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Lytic domain fusion constructs and methods of making and using same
EP4035685A1 (fr) 2012-10-30 2022-08-03 Esperance Pharmaceuticals, Inc. Conjugués anticorps-médicament et procédés d'utilisation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179573A (en) * 1974-07-01 1979-12-18 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai (2S,3R)-3-amino-2-hydroxy-4-phenylbutanoic acid
US4052449A (en) * 1974-07-01 1977-10-04 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Biologically active substance, bestatin, and production thereof
US4029547A (en) * 1974-07-01 1977-06-14 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Biologically active substance, bestatin, and production thereof
US5159060A (en) * 1988-05-27 1992-10-27 Mayo Foundation For Medical Education And Research Cytotoxic boronic acid peptide analogs
US5114921A (en) * 1988-05-27 1992-05-19 The Children's Hospital Of Philadelphia Amphiphilic peptides and use thereof
US5106948A (en) * 1988-05-27 1992-04-21 Mao Foundation For Medical Education And Research Cytotoxic boronic acid peptide analogs
US5217956A (en) * 1988-10-21 1993-06-08 The Children's Hospital Of Philadelphia Composition and treatment with biologically active peptides and certain anions
US5254535A (en) * 1989-04-17 1993-10-19 The Children's Hospital Of Pennsylvania Composition and treatment with biologically active peptides and antibiotic
US5045531A (en) * 1989-12-18 1991-09-03 Magainin Sciences Inc. Wound treatment employing biologically active ion channel forming peptides and proteins

Also Published As

Publication number Publication date
WO1994019369A1 (fr) 1994-09-01

Similar Documents

Publication Publication Date Title
AU4230196A (en) Treatment of pancreatic tumors with peptide yy and analogs thereof
AU3822993A (en) The use of inhibitors of plasminogen activators for the treatment of inflammations and wounds
AU7323994A (en) Medical pump and method of programming
AU3993795A (en) Peptide compounds for prevention and/or treatment of no-mediated diseases
AU6897094A (en) Identification and use of protease inhibitors
AU6391394A (en) Medical devices and methods of manufacture
AU2381895A (en) Treatment of warts using anthralins and occlusion
AU3321595A (en) Recombinant production of biologically active peptides and proteins
AU3844597A (en) Peptides for treatment of inflammation and shock
AU4840293A (en) Cloning and expression of pur protein
AU8011694A (en) Casket and method of making same
AU5600994A (en) Reduced and controlled surface binding of biologically active molecules
AU8806491A (en) Active fragments of fibroblast growth factor
AU5743194A (en) Treatment of dermatological malignancies with biologically active peptides
AU5081193A (en) Treatment of gynecological malignancies with biologically active peptides
AU4362696A (en) Growth inhibitory peptide and methods of using same
AU1636492A (en) Peptides having thrombospondin-like activity and their therapeutic use
SG42309A1 (en) Medical use of enzymes
AU6251594A (en) Treatment of cancerous growths with biologically active peptides and protease inhibitors
AU3827093A (en) Enzymatic treatment of denatured natural protein process and products thereof
AU6356494A (en) Treatment of microsporidial and acanthamoeba keratoconjunctivitis with topical fumagillin
AU5548694A (en) Peptide inhibitors of tyrosine kinases and therapeutic uses thereof
AU1720097A (en) Biologically active ureido derivatives useful in the treatment of multiple sclerosis
AU2766597A (en) Biologically active protein (collagen fragment hf-coll-18/514cf) for inhibiting the growth of tumours and capillary profilerations
AU7457594A (en) New combination of active substances containing esupron and levodopa